| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/2009 | US20090136474 Stabilized Protease Composition |
| 05/28/2009 | US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | US20090136472 Use of thiazole derivatives and analogues in disorders caused by free fatty acids |
| 05/28/2009 | US20090136470 Regulatory t cells and methods of making and using same |
| 05/28/2009 | US20090136465 Therapeutic Gene-Switch Constructs and Bioreactors for the Expression of Biotherapeutic Molecules, and Uses Thereof |
| 05/28/2009 | US20090136463 Schwann Cell Bridge Implants and Phosphodiesterase Inhibitors to Stimulate CNS Nerve Regeneration |
| 05/28/2009 | US20090136453 Methods for treating pain |
| 05/28/2009 | US20090136450 Therapy for neurological diseases |
| 05/28/2009 | US20090136449 Tetracyclic Indole Derivatives as Antiviral Agents |
| 05/28/2009 | US20090136448 Antiviral 2-Carboxy-Thiophene Compounds |
| 05/28/2009 | US20090136443 Drug Carrier |
| 05/28/2009 | US20090136442 Erythropoietin receptor peptide formulations and uses |
| 05/28/2009 | US20090136440 Mixtures of phosphorus-containing compounds, a process for their preparation, and their use as flame retardants |
| 05/28/2009 | US20090136438 Photo-protective dermatological formulations and methods of using the same |
| 05/28/2009 | US20090136437 Cosmetic and dermatological formulations including isononyl benzoate |
| 05/28/2009 | US20090136431 Stilbene Like Compounds as Novel HDAC Inhibitors |
| 05/28/2009 | US20090136430 Antihistamine/Corticosteroid preparations for the treatment of atopic dermatitis |
| 05/28/2009 | US20090136429 Combination of Anticholinergics and Inhibitors of Phosphodiesterase Type 4 For The Treatment of Respiratory Disease |
| 05/28/2009 | US20090136419 parenterally administering a dose of samarium ethylenediaminetetramethylenephosphonic acid (EDTMP); and carboplatin or taxoids; anticarcinogenic, antitumor, and antantiproliferative agents; autoimmune, infectious , metabolic or genetic disorders |
| 05/28/2009 | DE19681420B4 Vorrichtung und Bereitstellungsverfahren für eine transdermale Elektrotransport-Abgabe von Fentanyl und Sufentanil Apparatus and method for providing a transdermal electrotransport delivery of fentanyl and sufentanil |
| 05/28/2009 | DE102007055483A1 Kosmetische und dermatologische Formulierungen enthaltend Isononylbenzoat Cosmetic and dermatological formulations comprising isononyl |
| 05/28/2009 | DE102007055046A1 Infusionslösung Solution for infusion |
| 05/28/2009 | CA2722591A1 Substituted benzoazole pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | CA2722586A1 Substituted benzoazole pde4 inhibitors for treating inflammatory, cardiovascular and cns disorders |
| 05/28/2009 | CA2722582A1 Biaryl pde4 inhibitors for treating inflammation |
| 05/28/2009 | CA2706596A1 Tapentadol compositions |
| 05/28/2009 | CA2706586A1 Novel compounds as cannabinoid receptor ligands and uses thereof |
| 05/28/2009 | CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 05/28/2009 | CA2706465A1 Haloallylamine inhibitors of ssao/vap-1 and uses therefor |
| 05/28/2009 | CA2706404A1 Preparation for body surface application and preparation for body suface application-holding sheet |
| 05/28/2009 | CA2706391A1 Spiropiperidines for use as tryptase inhibitors |
| 05/28/2009 | CA2706369A1 Antibacterial aminoglycoside analogs |
| 05/28/2009 | CA2706328A1 Cycloalkyloxy- and heterocycloalkyloxypyridine compounds as modulators of the histamine h3 receptor |
| 05/28/2009 | CA2706327A1 2',4'-substituted nucleosides as antiviral agents |
| 05/28/2009 | CA2706304A1 Modulation of the immune response |
| 05/28/2009 | CA2706203A1 Use of mnk inhibitors for the treatment of alzheimer's disease |
| 05/28/2009 | CA2706102A1 Small-molecule modulators of trp-p8 activity |
| 05/28/2009 | CA2706075A1 Cancer diagnostic and therapeutic methods that target plk4/sak |
| 05/28/2009 | CA2705965A1 External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 05/28/2009 | CA2705944A1 Methods and compositions for inhibiting integrins using tellurium-containing compounds |
| 05/28/2009 | CA2705936A1 Use of omega-3-fatty acids for pain relief |
| 05/28/2009 | CA2705836A1 Treatment of oral pharyngeal dysphagia |
| 05/28/2009 | CA2705834A1 Non-nucleoside reverse transcriptase inhibitors |
| 05/28/2009 | CA2705734A1 Vaginal delivery system |
| 05/28/2009 | CA2705662A1 New human papilloma virus inhibitors and pharmaceutical compositions containing same |
| 05/28/2009 | CA2705599A1 New compounds |
| 05/28/2009 | CA2705596A1 New compounds |
| 05/28/2009 | CA2705530A1 Phospholipid compositions and uses thereof |
| 05/28/2009 | CA2705410A1 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 05/28/2009 | CA2705405A1 New compounds |
| 05/28/2009 | CA2705296A1 Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators |
| 05/28/2009 | CA2705183A1 Vaginal lubricant comprising hyaluronic acid |
| 05/28/2009 | CA2705011A1 Biaryl substituted diazabicycloalkane derivatives |
| 05/28/2009 | CA2704883A1 New compounds |
| 05/28/2009 | CA2704882A1 Use of amorolfine for treating a nail disease by iontophoresis |
| 05/28/2009 | CA2704214A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/28/2009 | CA2703893A1 Compound |
| 05/28/2009 | CA2703887A1 {[5-(phenyl)-6-phenylpyrrolo[2,1-f][2,1,4]triazin-4-yl]amino}carboxylic acid derivatives and related compounds as prostacyclin (pgi2) ip receptor activators for treating cardiovascular disorders |
| 05/28/2009 | CA2703283A1 Method for treating hematopoietic neoplasms |
| 05/28/2009 | CA2699306A1 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof |
| 05/28/2009 | CA2699305A1 Polymorphs of sunitinib base and processes for preparation thereof |
| 05/28/2009 | CA2695605A1 Pyrazolone derivative emulsion formulations |
| 05/27/2009 | EP2062899A1 Process for producing carnosol from carnosic acid |
| 05/27/2009 | EP2062898A2 Spirocyclic cyclohexane derivatives |
| 05/27/2009 | EP2062895A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 05/27/2009 | EP2062893A1 Fused imidazoles for cancer treatment |
| 05/27/2009 | EP2062892A1 Hypertension-ameliorating agent |
| 05/27/2009 | EP2062890A1 Tricyclic thrombin receptor antagonist |
| 05/27/2009 | EP2062889A1 Compounds |
| 05/27/2009 | EP2062887A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity |
| 05/27/2009 | EP2062886A1 Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 05/27/2009 | EP2062885A1 Acid addition salts of imatinib and formulations comprising the same |
| 05/27/2009 | EP2062884A1 Novel phenylacetic acid derivative |
| 05/27/2009 | EP2062883A1 Insulin sensitivity improving agent |
| 05/27/2009 | EP2062880A1 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2062878A1 Hydrazine amide derivative |
| 05/27/2009 | EP2062875A1 New polymorphic forms of n-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide |
| 05/27/2009 | EP2062874A1 Process and intermediates for the preparation of aliskiren |
| 05/27/2009 | EP2062598A1 Gel type enteric nutrient |
| 05/27/2009 | EP2062597A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 05/27/2009 | EP2062595A1 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 05/27/2009 | EP2062593A2 Method for producing preparation containing bioactive peptide |
| 05/27/2009 | EP2062586A2 Use of low doses of oligonucleotides antisense to tgf-beta, vegf, interleukin-10, c-jun, c-fos or prostaglandin e2 genes in the treatment of tumors |
| 05/27/2009 | EP2062585A1 The antibiotics composition comprising aminoglycoside antibiotics |
| 05/27/2009 | EP2062584A1 Adhesive preparation |
| 05/27/2009 | EP2062583A2 Therapeutic applications of pro-apoptotic benzodiazepines |
| 05/27/2009 | EP2062582A1 The antibiotics composition comprising beta-lactam antibiotics and buffers |
| 05/27/2009 | EP2062581A1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents |
| 05/27/2009 | EP2062580A1 Use of dipyridamole or mopidamole for treatment and prevention of thromboembolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of trombin receptors |
| 05/27/2009 | EP2062579A1 Solid pharmaceutical composition for oral administration comprising optically stable ramosetron |
| 05/27/2009 | EP2062578A1 Novel use of chemical compounds for the treatment of AIDS |
| 05/27/2009 | EP2062577A1 Oleanolic acid derivatives as NO production inhibitors |
| 05/27/2009 | EP2062576A1 Adhesive preparation |
| 05/27/2009 | EP2062575A1 Adhesive preparation |
| 05/27/2009 | EP2062574A1 Composition comprising reduced coenzyme q10 and lysolecithin |
| 05/27/2009 | EP2062572A1 Pharmaceutical compositions |
| 05/27/2009 | EP2062570A1 A method for obtaining stable micro-emulsions of derivatives of oxycarotenoids of short-chain organic acids, micro-emulsions obtained, and formulation which contains these |
| 05/27/2009 | EP2062181A2 Prediction of an agent's or agents' activity across different cells and tissue types |
| 05/27/2009 | EP2061799A2 Methods and compositions for the use of lysine riboswitches |